tykhr
sign in
free sign up
Fennec Pharmaceuticals Inc
Biotechnology
Healthcare
FENC
27.58 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.66
52 week high
9.24
high
8.81
52 week low
0.00
low
8.41
growth
62.02 %
previous Close
8.67
P/E ratio
market cap
255 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
13.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top